treat news - Search News

FDA approves Spravato, first monotherapy nasal spray to treat depression

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

Fox Business · 12h

J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

KSNT Topeka on MSN · 3h

FDA allows standalone use of nasal spray antidepressant Spravato

The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression.

WAVY Norfolk on MSN · 12h

Nose spray to treat depression? FDA approves first-of-its-kind medicine

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

8hon MSN

Treat eating disorders as an emergency, MPs urge

Lives are being lost and families torn apart because of "woefully inadequate care" for people with eating disorders, ...

20h

Johnson & Johnson Gets FDA OK For Spravato as Monotherapy

Johnson & Johnson has won Food and Drug Administration expanded approval of its Spravato nasal spray as a lone therapy for adults with treatment-resistant depression. J&J on Tuesday said the green ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Trending now